Primary hyperparathyroidism

References

• Zink AR, Panzer S, Fesq-Martin M, Burger-Heinrich E, Wahl J, Nerlich AG. Evidence for a 7000-year-old case of primary hyperparathyroidism. JAMA293, 40–42 (2005).
   PubMedGoogle Scholar
• Fraser WD. Hyperparathyroidism. Lancet374, 145–158 (2009).
   PubMed Web of Science ®Google Scholar
• Wermers RA, Khosla S, Atkinson EJ et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J. Bone Miner. Res.21, 171–177 (2006).
   PubMed Web of Science ®Google Scholar
• Khan AA, Bilezikian JP, Potts JT Jr. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J. Clin. Endocrinol. Metab.94, 333–334 (2009).
   PubMed Web of Science ®Google Scholar
• Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J. Bone Miner. Res.17(Suppl. 2), N18–N23 (2002).
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab.94, 335–339 (2009).
   PubMed Web of Science ®Google Scholar
• Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O’Fallon WM, Melton LJ 3rd. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann. Intern. Med.126, 433–440 (1997).
   PubMed Web of Science ®Google Scholar
• DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch. Pathol. Lab. Med.132, 1251–1262 (2008).
   PubMed Web of Science ®Google Scholar
• Farford B, Presutti RJ, Moraghan TJ. Nonsurgical management of primary hyperparathyroidism. Mayo Clin. Proc.82, 351–355 (2007).
   PubMed Web of Science ®Google Scholar
• Lundgren E, Hagstrom EG, Lundin J et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J. Surg.26, 931–936 (2002).
   PubMed Web of Science ®Google Scholar
• Sitges-Serra A, Bergenfelz A. Clinical update: sporadic primary hyperparathyroidism. Lancet370, 468–470 (2007).
   PubMed Web of Science ®Google Scholar
• Coker LH, Rorie K, Cantley L et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann. Surg.242, 642–650 (2005).
   PubMed Web of Science ®Google Scholar
• Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab.94, 366–372 (2009).
   PubMed Web of Science ®Google Scholar
• Babar-Craig H, Quaglia A, Stearns M. Parathyroid carcinoma: a report of two cases and a concise review and update of the literature. J. Laryngol. Otol.119, 577–580 (2005).
   PubMed Web of Science ®Google Scholar
• Sahasranam P, Tran MT, Mohamed H, Friedman TC. Multiglandular parathyroid carcinoma: a case report and brief review. South Med. J.100, 841–844 (2007).
   PubMed Web of Science ®Google Scholar
• Rawat N, Khetan N, Williams DW, Baxter JN. Parathyroid carcinoma. Br. J. Surg.92, 1345–1353 (2005).
   PubMed Web of Science ®Google Scholar
• Colaco SM, Si M, Reiff E, Clark OH. Hyperparathyroidism after radioactive iodine therapy. Am. J. Surg.194, 323–327 (2007).
   PubMed Web of Science ®Google Scholar
• Eastell R, Arnold A, Brandi ML et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab.94, 340–350 (2009).
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta SK, Sukumar R. Hyperparathyroidism and malnutrition with severe vitamin D deficiency. World J. Surg.33(11), 2303–2313 (2009).
   PubMed Web of Science ®Google Scholar
• Untch BR, Barfield ME, Dar M, Dixit D, Leight GS Jr, Olson JA Jr. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism. Surgery142, 1022–1026 (2007).
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Potts JT Jr. Asymptomatic primary hyperparathyroidism: new issues and new questions – bridging the past with the future. J. Bone Miner. Res.17Suppl. 2, N57–N67 (2002).
   Google Scholar
• Mollerup CL, Vestergaard P, Frokjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ325, 807 (2002).
   PubMedGoogle Scholar
• Dotzenrath CM, Kaetsch AK, Pfingsten H et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J. Surg.30, 680–685 (2006).
   PubMed Web of Science ®Google Scholar
• Benge JF, Perrier ND, Massman PJ, Meyers CA, Kayl AE, Wefel JS. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J. Int. Neuropsychol. Soc.15, 1002–1011 (2009).
   PubMed Web of Science ®Google Scholar
• Letizia C, Ferrari P, Cotesta D et al. Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J. Hum. Hypertens.19, 901–906 (2005).
   PubMed Web of Science ®Google Scholar
• Piovesan A, Molineri N, Casasso F et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf.)50, 321–328 (1999).
   PubMed Web of Science ®Google Scholar
• Vazquez-Diaz O, Castillo-Martinez L, Orea-Tejeda A et al. Reversible changes of electrocardiographic abnormalities after parathyroidectomy in patients with primary hyperparathyroidism. Cardiol. J.16, 241–245 (2009).
   PubMed Web of Science ®Google Scholar
• Niederle B, Stefenelli T, Glogar D, Woloszczuk W, Roka R, Mayr H. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery108, 1052–1056; discussion 1056–1057 (1990).
   PubMed Web of Science ®Google Scholar
• Kiewiet RM, Ponssen HH, Janssens EN, Fels PW. Ventricular fibrillation in hypercalcaemic crisis due to primary hyperparathyroidism. Neth. J. Med.62, 94–96 (2004).
   PubMed Web of Science ®Google Scholar
• Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann. Surg.222, 402–412; discussion 412–404 (1995).
   PubMed Web of Science ®Google Scholar
• Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases. Aust. NZ J. Surg.68, 117–119 (1998).
   PubMedGoogle Scholar
• Sato H, Abe K, Oshima N et al. Primary hyperparathyroidism with duodenal ulcer and H. pylori infection. Intern. Med.41, 377–380 (2002).
   PubMed Web of Science ®Google Scholar
• Peacock M. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J. Bone Miner. Res.17(Suppl. 2), N87–N94 (2002).
   PubMedGoogle Scholar
• Rubin MR, Bilezikian JP, McMahon DJ et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J. Clin. Endocrinol. Metab.93, 3462–3470 (2008).
   PubMed Web of Science ®Google Scholar
• Khalil PN, Heining SM, Huss R et al. Natural history and surgical treatment of brown tumor lesions at various sites in refractory primary hyperparathyroidism. Eur. J. Med. Res.12, 222–230 (2007).
   PubMed Web of Science ®Google Scholar
• Rubin MR, Silverberg SJ. Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy. Curr. Rheumatol. Rep.4, 179–185 (2002).
   PubMedGoogle Scholar
• Cardenas MG, Vigil KJ, Talpos GB, Lee MW, Peterson E, Rao DS. Prevalence of Type 2 diabetes mellitus in patients with primary hyperparathyroidism. Endocr. Pract.14, 69–75 (2008).
   PubMedGoogle Scholar
• Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J. Clin. Endocrinol. Metab.90, 1525–1530 (2005).
   PubMed Web of Science ®Google Scholar
• Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab.94, 351–365 (2009).
   PubMed Web of Science ®Google Scholar
• Nilsson IL, Wadsten C, Brandt L, Rastad J, Ekbom A. Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery136, 981–987 (2004).
   PubMed Web of Science ®Google Scholar
• Hagstrom E, Hellman P, Larsson TE et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation119, 2765–2771 (2009).
   PubMed Web of Science ®Google Scholar
• Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ. Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab.90, 3326–3330 (2005).
   PubMed Web of Science ®Google Scholar
• Streeten EA, Munir K, Hines S et al. Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis. Endocr. Pract.14, 155–161 (2008).
   PubMedGoogle Scholar
• Kepez A, Harmanci A, Hazirolan T et al. Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients. Int. J. Cardiovasc. Imaging25, 187–193 (2009).
   PubMed Web of Science ®Google Scholar
• Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism. Eur. J. Endocrinol.160, 863–868 (2009).
   PubMed Web of Science ®Google Scholar
• Walker MD, Silverberg SJ. Cardiovascular aspects of primary hyperparathyroidism. J. Endocrinol. Invest.31, 925–931 (2008).
   PubMed Web of Science ®Google Scholar
• Walker MD, Fleischer J, Rundek T et al. Carotid vascular abnormalities in primary hyperparathyroidism. J. Clin. Endocrinol. Metab.94, 3849–3856 (2009).
   PubMed Web of Science ®Google Scholar
• Luboshitzky R, Chertok-Schaham Y, Lavi I, Ishay A. Cardiovascular risk factors in primary hyperparathyroidism. J. Endocrinol. Invest.32, 317–321 (2009).
   PubMed Web of Science ®Google Scholar
• Nilsson IL, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery137, 632–638 (2005).
   PubMed Web of Science ®Google Scholar
• Walker MD, Silverberg SJ. Parathyroidectomy in asymptomatic primary hyperparathyroidism: improves “bones” but not “psychic moans”. J. Clin. Endocrinol. Metab.92, 1613–1615 (2007).
   PubMed Web of Science ®Google Scholar
• Walker MD, McMahon DJ, Inabnet WB et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J. Clin. Endocrinol. Metab.94, 1951–1958 (2009).
   PubMed Web of Science ®Google Scholar
• Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab.89, 5415–5422 (2004).
   PubMed Web of Science ®Google Scholar
• Ambrogini E, Cetani F, Cianferotti L et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab.92, 3114–3121 (2007).
   PubMed Web of Science ®Google Scholar
• Bollerslev J, Jansson S, Mollerup CL et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab.92, 1687–1692 (2007).
   PubMed Web of Science ®Google Scholar
• Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med.341, 1249–1255 (1999).
   PubMed Web of Science ®Google Scholar
• Lundgren E, Lind L, Palmer M, Jakobsson S, Ljunghall S, Rastad J. Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery130, 978–985 (2001).
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N. Engl. J. Med.357, 266–281 (2007).
   PubMed Web of Science ®Google Scholar
• Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab.92, 3001–3005 (2007).
   PubMed Web of Science ®Google Scholar
• Perrier ND. Impact of 25 hydroxyvitamin D deficiency in perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism. Surgery142, 1027–1029 (2007).
   PubMed Web of Science ®Google Scholar
• Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J. Clin. Endocrinol. Metab.90, 2122–2126 (2005).
   PubMed Web of Science ®Google Scholar
• Ciacci C, Cirillo M, Mellone M, Basile F, Mazzacca G, De Santo NG. Hypocalciuria in overt and subclinical celiac disease. Am. J. Gastroenterol.90, 1480–1484 (1995).
   PubMed Web of Science ®Google Scholar
• Mikhail N, Cope D. Evaluation and treatment of primary hyperparathyroidism. JAMA294, 2700 (2005).
   PubMedGoogle Scholar
• Phitayakorn R, McHenry CR. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J. Am. Coll. Surg.206, 1106–1115 (2008).
   PubMed Web of Science ®Google Scholar
• Joukhadar R, Bright T. Calciphylaxis in primary hyperparathyroidism: a case report and brief review. South Med. J.102, 318–321 (2009).
   PubMed Web of Science ®Google Scholar
• Nigwekar SU. An unusual case of nonhealing leg ulcer in a diabetic patient. South Med. J.100, 851–852 (2007).
   PubMed Web of Science ®Google Scholar
• Roberts WC, Waller BF. Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am. J. Med.71, 371–384 (1981).
   PubMed Web of Science ®Google Scholar
• Henegar JR, Coleman JP, Cespedes J, Hughson MD. Glomerular calcification in hypercalcemic nephropathy. Arch. Pathol. Lab. Med.127, E80–E85 (2003).
   Google Scholar
• NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann. Intern. Med.114, 593–597 (1991).
   PubMed Web of Science ®Google Scholar
• Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J. Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery136, 1281–1288 (2004).
   PubMed Web of Science ®Google Scholar
• VanderWalde LH, Liu IL, O’Connell TX, Haigh PI. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Arch. Surg.141, 885–889; discussion 889–891 (2006).
   PubMedGoogle Scholar
• Silverberg SJ, Brown I, Bilezikian JP. Age as a criterion for surgery in primary hyperparathyroidism. Am. J. Med.113, 681–684 (2002).
   PubMed Web of Science ®Google Scholar
• Odvina CV, Sakhaee K, Heller HJ et al. Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol. Res.35, 123–128 (2007).
   PubMedGoogle Scholar
• Corbetta S, Baccarelli A, Aroldi A et al. Risk factors associated to kidney stones in primary hyperparathyroidism. J. Endocrinol. Invest.28, 122–128 (2005).
   PubMed Web of Science ®Google Scholar
• Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh QY, Stoller ML. Patients with primary hyperparathyroidism – why do some form stones? J. Urol.181, 2141–2145 (2009).
   PubMed Web of Science ®Google Scholar
• McGill J, Sturgeon C, Kaplan SP, Chiu B, Kaplan EL, Angelos P. How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies. J. Am. Coll. Surg.207, 246–249 (2008).
   PubMed Web of Science ®Google Scholar
• Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am. J. Roentgenol.188, 1706–1715 (2007).
   PubMed Web of Science ®Google Scholar
• Rodgers SE, Hunter GJ, Hamberg LM, et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery140, 932–940; discussion 940–941 (2006).
   PubMed Web of Science ®Google Scholar
• Reidel MA, Schilling T, Graf S et al. Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism. Surgery140, 907–913; discussion 913 (2006).
   PubMed Web of Science ®Google Scholar
• Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann. Surg.246, 976–980; discussion 980–971 (2007).
   PubMed Web of Science ®Google Scholar
• Russell CF, Dolan SJ, Laird JD. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br. J. Surg.93, 418–421 (2006).
   PubMed Web of Science ®Google Scholar
• Bergenfelz A, Kanngiesser V, Zielke A, Nies C, Rothmund M. Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br. J. Surg.92, 190–197 (2005).
   PubMed Web of Science ®Google Scholar
• Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab.94, 373–381 (2009).
   PubMed Web of Science ®Google Scholar
• Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J. Bone Miner. Res.16, 113–119 (2001).
   PubMed Web of Science ®Google Scholar
• Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ. Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. J. Clin. Endocrinol. Metab.87, 4482–4489 (2002).
   PubMed Web of Science ®Google Scholar
• Chow CC, Chan WB, Li JK et al. Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab.88, 581–587 (2003).
   PubMed Web of Science ®Google Scholar
• Khan AA, Bilezikian JP, Kung AW et al. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab.89, 3319–3325 (2004).
   PubMed Web of Science ®Google Scholar
• Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women. Arch. Intern. Med.160, 2161–2166 (2000).
   PubMedGoogle Scholar
• Diamond T, Ng AT, Levy S, Magarey C, Smart R. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report. Osteoporos. Int.6, 329–333 (1996).
   PubMed Web of Science ®Google Scholar
• Shoback D. Update in osteoporosis and metabolic bone disorders. J. Clin. Endocrinol. Metab.92, 747–753 (2007).
   PubMed Web of Science ®Google Scholar
• Steddon SJ, Cunningham J. Calcimimetics and calcilytics – fooling the calcium receptor. Lancet365, 2237–2239 (2005).
   PubMed Web of Science ®Google Scholar
• Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J. Clin. Endocrinol. Metab.88, 5644–5649 (2003).
   PubMed Web of Science ®Google Scholar
• Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab.90, 135–141 (2005).
   PubMed Web of Science ®Google Scholar
• Silverberg SJ, Rubin MR, Faiman C et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J. Clin. Endocrinol. Metab.92, 3803–3808 (2007).
   PubMed Web of Science ®Google Scholar
• Marcocci C, Chanson P, Shoback D et al. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. J. Clin. Endocrinol. Metab.94(8), 2766–2772 (2009).
   PubMed Web of Science ®Google Scholar
• Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet. Gynecol. Surv.57, 365–376 (2002).
   PubMed Web of Science ®Google Scholar
• Ficinski ML, Mestman JH. Primary hyperparathyroidism during pregnancy. Endocr. Pract.2, 362–367 (1996).
   PubMedGoogle Scholar
• Harsoulis F, Karayiannis B, Karvounaris D, Mamopoulos M. Primary hyperparathyroidism in pregnancy. J. Obstet. Gynaecol.20, 188–189 (2000).
   PubMedGoogle Scholar
• Jesudason WV, Murphy J, England RJ. Primary hyperparathyroidism in pregnancy. J. Laryngol. Otol.118, 891–892 (2004).
   PubMed Web of Science ®Google Scholar
• Amaya Garcia M, Acosta Feria M, Soto Moreno A et al. Primary hyperparathyroidism in pregnancy. Gynecol. Endocrinol.19, 111–114 (2004).
   PubMed Web of Science ®Google Scholar
• Perin E, Cacciaguerra G, Lapenna R, Catena C, Sechi LA, Marchesoni D. Primary hyperparathyroidism in pregnancy. Fertil. Steril.90, e2013–e2015 (2008).
   Google Scholar
• Iqbal N, Steinberg H, Aldasouqi S, Edmondson JW. Nephrolithiasis during pregnancy secondary to primary hyperparathyroidism. Urology57, 554 (2001).
   PubMedGoogle Scholar
• Hong MK, Hsieh CT, Chen BH, Tu ST, Chou PH. Primary hyperparathyroidism and acute pancreatitis during the third trimester of pregnancy. J. Matern. Fetal. Med.10, 214–218 (2001).
   PubMedGoogle Scholar
• Hultin H, Hellman P, Lundgren E et al. Association of parathyroid adenoma and pregnancy with preeclampsia. J. Clin. Endocrinol. Metab.94, 3394–3399 (2009).
   PubMed Web of Science ®Google Scholar
• Schnatz PF, Thaxton S. Parathyroidectomy in the third trimester of pregnancy. Obstet. Gynecol. Surv.60, 672–682 (2005).
   PubMed Web of Science ®Google Scholar
• Iqbal N, Aldasouqi S, Peacock M, Mohammed IA, Edmondson JW. Life-threatening hypercalcemia associated with primary hyperparathyroidism during pregnancy: case report and review of literature. Endocr. Pract.5, 337–342 (1999).
   PubMedGoogle Scholar
• Norman J, Politz D, Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin. Endocrinol. (Oxf.)71, 104–109 (2009).
   PubMed Web of Science ®Google Scholar
• Jaafar R, Yun Boo N, Rasat R, Latiff HA. Neonatal seizures due to maternal primary hyperparathyroidism. J. Paediatr. Child Health40, 329 (2004).
   PubMedGoogle Scholar
• Ip P. Neonatal convulsion revealing maternal hyperparathyroidism: an unusual case of late neonatal hypoparathyroidism. Arch. Gynecol. Obstet.268, 227–229 (2003).
   PubMedGoogle Scholar
• Beattie GC, Ravi NR, Lewis M et al. Rare presentation of maternal primary hyperparathyroidism. BMJ321, 223–224 (2000).
   PubMedGoogle Scholar
• Shani H, Sivan E, Cassif E, Simchen MJ. Maternal hypercalcemia as a possible cause of unexplained fetal polyhydramnion: a case series. Am. J. Obstet. Gynecol.199, 410 e411–e415 (2008).
   PubMedGoogle Scholar
• Truong MT, Lalakea ML, Robbins P, Friduss M. Primary hyperparathyroidism in pregnancy: a case series and review. Laryngoscope118, 1966–1969 (2008).
   PubMed Web of Science ®Google Scholar